Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09VRX
|
|||
Former ID |
DNC005881
|
|||
Drug Name |
2-(4-methyl-1H-benzo[d]imidazol-2-yl)quinoxaline
|
|||
Synonyms |
CHEMBL198779; benzimidazole-quinoxaline, C3; SCHEMBL12834347; BDBM21217; ZINC13678106
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H12N4
|
|||
Canonical SMILES |
CC1=C2C(=CC=C1)NC(=N2)C3=NC4=CC=CC=C4N=C3
|
|||
InChI |
1S/C16H12N4/c1-10-5-4-8-13-15(10)20-16(19-13)14-9-17-11-6-2-3-7-12(11)18-14/h2-9H,1H3,(H,19,20)
|
|||
InChIKey |
HQNVISKJTIKRQJ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Derivatives of 4-amino-6-hydroxy-2-mercaptopyrimidine as novel, potent, and selective A3 adenosine receptor antagonists. J Med Chem. 2008 Mar 27;51(6):1764-70. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.